Case Type: Mergers & Acquisitions

AquaVenture Holdings Limited (WAAS) relating to its sale to Culligan International Company. Under the terms of the sale, each share of AquaVenture common stock will be converted into the right to receive $27.10 in cash for each share of AquaVenture common stock owned.

Telaria, Inc. (TLRA) related to its sale to The Rubicon Project, Inc. Under the terms of the agreement, each share of Telaria common stock will be converted into the right to receive 1.082 shares of Rubicon Project common stock for each Telaria common stock owned.

MSB Financial Corp. (MSBF) (“MSB Financial”) related to its sale to Kearny Financial Corp. Under the terms of the Merger, each share of MSB Financial common stock will be converted into the right to receive either (i) $18 in cash or (ii) 1.3 shares of Kearny’s common stock for each MSB financial common stock owned.

Southwest Georgia Financial Corporation (SGB) related to its sale to The First Bancshares, Inc. Under the terms of the Merger, each share of Southwest common stock will be converted into the right to receive one (1.00) share of First Bancshares common stock for each share of Southwest common stock owned.

Tallgrass Energy, LP (TGE) relating to its sale to Prairie Private Acquiror LP. Under the terms of the agreement, each Class A shares will be converted into the right to receive $22.45 in cash for each Class A share owned.

Texas Capital Bancshares, Inc. (TCBI) (“Texas Capital”) related to its sale to Independent Bank Group, Inc. Under the terms of the sale, each share of Texas Capital common stock will be converted into the right to receive 1.0311 shares of Independent Bank Group common stock for each share of Texas Capital common stock owned.

Aytu BioScience, Inc. (AYTU) relating to its purchase agreement with Cerecor Inc. We are investigating its Board of Directors for potential securities laws violations and/or breaches of fiduciary duties in connection with the Purchase Agreement with Cerecor Inc for its pediatric and primary care product lines (the “Purchase Agreement”).

Diplomat Pharmacy, Inc (DPLO) related to its sale to UnitedHealth Group Incorporated. Under the terms of the Merger, Diplomat shareholders will have the right to receive $4.00 in cash for each Diplomat common stock owned.

ArQule, Inc (ARQL) relating to its sale to Merck Sharp & Dohme Corp. Under the terms of the Merger, ArQule shareholders will have the right to receive $20.00 in cash for each share of ArQule common stock owned.

Synthorx, Inc (THOR) relating to its sale to Sonafi. Under the terms of the Agreement, Synthorx shareholders will receive $68.00 in cash for each share of Synthorx common stock owned.